ANTAGONISTIC ANTI-HTNFSF13B HUMAN ANTIBODIES
Application 210/KOLNP/2004 published 2006-04-07, filed 2004-02-16
Human monoclonal antibodies that specifically bind to TNFSF13b polypeptides are disclosed. These antibodies have high affinity for hTNFSF13b (e.g., KD = 10-8 M or less), a slow off rate for TNFSF13b dissociation (e.g., Koff = 10-3 sec-1 or less) and neutralize TNFSF13b activity in vitro and in vivo. The antibodies of the invention are useful in one embodiment for inhibiting TNFSF13b activity in a human subject suffering from a disorder in which hTNFSF13b activity is detrimental. Nucleic acids encoding the antibodies of the present invention, as well as, vectors and host cells for expressing them are also encompassed by the invention. (FIG. NIL)
Applicant
ELI LILLY AND COMPANY
Lilly Corporate Center, Indianapolis, IN 46285,USA.
Inventor
GELFANOVA, Valentina, Pavlovna HALE, John, Edward KIKLY, Kristine, Kay WITCHER, Derrick, Ryan RATHNACHALAM, Radhakrishnan
International Info
Classification: C12N
Publication Number: WO 03/016468
Application Date: 2002-08-15
Priority Information
60/312,808 US 2001-08-16